#Birinapant enhances #Gemcitabine’s anti-tumor efficacy in #TripleNegativeBreastCancer by inducing intrinsic pathway–dependent apoptosis, Xie et al report. #TNBC https://t.co/jDXnlom4PY https://t.co/2WJc7DzdFu
#Birinapant enhances #Gemcitabine’s anti-tumor efficacy in #TripleNegativeBreastCancer by inducing intrinsic pathway–dependent apoptosis, Xie et al report. #TNBC https://t.co/3CH5qD3f2D https://t.co/3a1YZkRQ8Y
RT @MCT_AACR: #Birinapant enhances #Gemcitabine’s anti-tumor efficacy in #TripleNegativeBreastCancer by inducing intrinsic pathway–dependen…
#Birinapant enhances #Gemcitabine’s anti-tumor efficacy in #TripleNegativeBreastCancer by inducing intrinsic pathway–dependent apoptosis, Xie et al report. #TNBC https://t.co/xCiBmqcGvm https://t.co/tC48URGzFe
Another academia work, this time from MD Anderson, on $MVIRB SMAC mimetic birinapant in combo w/ chemo in TNBC Birinapant Enhances Gemcitabine's Anti-tumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent Apoptosis https:/